The Successful Outcome
- Outlined expectations on how the joint HTA would appraise the evidence package and the likely outcome, including a risk assessment vs. going to individual country processes
- Identify if joint HTA route is a no-go vs. individual country HTA pathways for each scope market
- Advise on strategic levers that can be used to optimise joint HTA outcomes
- Develop phasing considerations for involvement of BeNeLuxA and FINOSE
![](https://partners4access.com/wp-content/uploads/2023/09/cs-gt5-1024x527.png)